4//SEC Filing
ONYX PHARMACEUTICALS INC 4
Accession 0001209191-07-048754
CIK 0001012140operating
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:17 PM ET
Size
9.0 KB
Accession
0001209191-07-048754
Insider Transaction Report
Form 4
GIOTTA GREGORY J
VP & Chief Legal Counsel
Transactions
- Sale
Common Stock
2007-08-14$32.00/sh−3,904$124,928→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-08-14−3,904→ 0 totalExercise: $10.52Exp: 2011-07-27→ Common Stock (3,904 underlying) - Exercise/Conversion
Common Stock
2007-08-14$10.52/sh+3,904$41,070→ 5,904 total
Footnotes (1)
- [F1]12.5% of the shares subject to the option become exercisable 6 months following the date of grant. The remaining shares become exercisable in equal monthly installments over the following 42 months for a total vesting schedule of 48 months.
Documents
Issuer
ONYX PHARMACEUTICALS INC
CIK 0001012140
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012140
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:17 PM ET
- Size
- 9.0 KB